Storia in 2 fonti

If AI helps speed up drug development, can the FDA keep up?

Anthropic says that its new tool can help scientists more quickly uncover and develop new drugs. But FDA approval still takes a long time.

Raccontata da

adexchanger.com

marketplace.org

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

marketplace.orgStai leggendo14 h fa

If AI helps speed up drug development, can the FDA keep up?

Anthropic released Claude Science in June to accelerate drug discovery and preclinical research with AI. FDA approval bottlenecks could negate AI-driven speed gains in development, forcing biotech managers to restructure timelines and budget planning.

originale

adexchanger.com22 h fa

Agentic AI Is Rewriting The Pharma Marketing Playbook | AdExchanger

AI is transforming how the pharma industry approaches drug development. On average, the industry invests $2.6 billion to bring a new treatment to market, taking 12 to 15 years with a 10% success rate. But pharma…

Leggi questa versione →

Timeline cronologica

giovedì 10 settembre 2026·adexchanger.com
Agentic AI Is Rewriting The Pharma Marketing Playbook | AdExchanger
AI is transforming how the pharma industry approaches drug development. On average, the industry invests $2.6 billion to bring a new treatment to market, taking 12 to 15 years…
giovedì 10 settembre 2026·marketplace.org
If AI helps speed up drug development, can the FDA keep up?
Anthropic says that its new tool can help scientists more quickly uncover and develop new drugs. But FDA approval still takes a long time.